BICO enables and automates the life science lab of the future

REPORT

Q3 2024

Report
Earnings Call Webcast
Presentation

Capital Markets Day 2024

Watch Now →

Download presentation →

press releases

11/28/24BICO completes the divestment of Nanoscribe
11/26/24RegulatoryPublication of BICO Group Interim Report January-September 2024
11/25/24CELLINK announces further right-sizing and launches sharpened commercial agenda
11/22/24BICO Group AB (publ) has repurchased convertible bonds to a total nominal amount of SEK 118m
11/21/24RegulatoryBICO has entered into an agreement to divest Nanoscribe
11/05/24Invitation to the presentation of BICO’s interim report Q3, 2024
10/18/24RegulatoryBICO’s Calendar for financial reporting: H2 2024 and 2025
10/09/24RegulatoryBICO Group AB’s Nomination Committee for the 2025 Annual General Meeting
09/17/24BICO’ Capital Markets Day 2024: Launch of BICO’s Updated strategy, BICO 2.0
08/20/24RegulatoryPublication of BICO Group Interim report January-June 2024
08/15/24Invitation to BICO’s Capital Markets Day 2024
08/06/24Invitation to the presentation of BICO’s interim report Q2, 2024
07/10/24RegulatoryAndréas Joersjö appointed as General Counsel for BICO Group AB
05/20/24RegulatoryBulletin from Annual General Meeting in BICO Group AB (publ)
05/13/24RegulatoryBICO publishes adjusted Annual and Sustainability Report 2023
05/07/24RegulatoryPublication of BICO Group Interim report January-March 2024
05/06/24RegulatoryBICO changes method for impairment test of goodwill resulting in retroactive impairment of goodwill for 2022 and 2023 and provides preliminary figures for Q1 2024
04/23/24Invitation to the presentation of BICO’s interim report Q1, 2024
04/18/24RegulatoryAnders Fogelberg appointed as Chief Commercial Officer for BICO Group AB (publ)
04/16/24RegulatoryNotice to attend the Annual General Meeting in BICO Group AB (publ)
03/15/24RegulatoryFounders leave after eight years
03/15/24RegulatoryBICO Publishes Annual and Sustainability Report 2023
02/20/24RegulatoryPublication of BICO Group Year-end report 2023
02/14/24RegulatoryBICO announces goodwill impairment of SEK 582m and provides preliminary figures for Q4 2023
02/12/24Invitation to the presentation of BICO’s interim report Q4, 2023
01/25/24RegulatoryCatharina Nordlund is appointed Global Head of HR for BICO Group AB (publ)
12/04/23RegulatoryBICO company Biosero has signed an agreement to develop laboratory automation solutions to a value of 28 MUSD
11/30/23BICO has completed the divestment of the Berlin property for a total of EUR 21m
11/14/23RegulatoryPublication of BICO Group interim report July – September 2023
11/13/23Maria Forss assumes office as BICO’s CEO and President on November 20, 2023
11/13/23BICO has divested Ginolis
11/09/23RegulatoryBICO Group AB Nomination Committee 2024 AGM appointed
11/06/23Invitation to the presentation of BICO’s interim report Q3, 2023
11/01/23RegulatoryBICO releases preliminary revenue, EBITDA, and cash flow from operating activities for Q3, 2023
08/22/23Appointed CEO and President Maria Forss has acquired shares in BICO Group AB (publ)
08/22/23Invitation to webcast with CEO and Chairman of the Board: company update with regards to CEO-change, Q2 report and goodwill impairment
08/22/23RegulatoryPublication of BICO Group interim report April – June 2023
08/21/23RegulatoryBICO announces goodwill impairment predominantly due to increased WACC, and write-downs of assets
08/21/23RegulatoryMaria Forss is appointed new President and CEO of BICO Group AB (publ)
08/11/23Invitation to the presentation of BICO’s interim report Q2, 2023
08/03/23BICO divests Berlin property for a total of EUR 21m
07/27/23Initiating next phase in integration process with enhanced commercial strategy and customer-centric operating model to be established in H2, 2023
07/03/23Next step in Sartorius partnership finalized: several sub-sales and distribution agreements as well as R&D project agreements have been signed
05/09/23RegulatoryBulletin from Annual General Meeting in BICO Group AB (publ)
05/04/23RegulatoryPublication of BICO Group interim report January – March 2023
04/24/23Invitation to the presentation of BICO’s interim report Q1, 2023
04/04/23RegulatoryNotice to attend the Annual General Meeting in BICO Group AB (publ)
03/17/23RegulatoryBICO Publishes Annual Report and Sustainability Report 2022
Learn more

FINANCIAL REPORTS

Learn more

Calendar

Who we are
Business areas

Strategy BICO 2.0

BICO’s updated strategy was launched during the Capital Markets Day held on September 17, 2024, with focus on the Group’s strategic direction for sustainable profitable growth.

Read more

Lab Automation

One key commercial focus area in the updated strategy is enabling end-to-end lab automation. In addition, BICO has introduced a new business area structure where Lab Automation has been established as a stand alone business area.

 

Lab Automation is here to stay so why not explore what it is all about?

Learn more

Bico by numbers

Net Sales April-June 2024

450 M SEK

Organic Growth April-June 2024

-11.7 %

Employees

750 +

Instruments in the Field

45000 +

Publications

11000 +

Countries

25 +
Investor relations
Investor Relations
06 kopiera
DSC_7861 kopiera
20 kopiera
Foto: Felix Groteloh
lab_16 (1) kopiera
IMG_7983 (1)
CYTENA_116_By_Felix_Groteloh
covid-19-bico
bico-biosciences-hero

BICO News Feed​

September 23, 2024
Cytena Unlocking the Future of Medicine: The Promise and Techniques of Allogeneic Stem Cell Therapies
September 16, 2024
Cytena Automation in iPSC-based Cell Therapy Generation: Increasing Efficiency and Consistency
September 3, 2024
Bico MatTek Life Sciences Licenses Cutting-Edge In Vitro Human Tissue Technology to Leading Production Laboratory in China
August 1, 2024
Cellenion Scale up your single cell proteomics to thousands of cells with nPOP
Learn more